 Assenagon Asset Management S.A. purchased a new position in shares of Charles River Laboratories Intl. Inc NYSE:CRL in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 42,984 shares of the medical research companys stock, valued at approximately 9,734,000. Assenagon Asset Management S.A. ... 